Company news

ENDRA Life Sciences Inc. news in 2023

ENDRA Life Sciences Inc.'s news releases, calls and decks from 2023, newest first.

View company

ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology

November 28, 2023

ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

November 13, 2023

ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents

November 7, 2023

ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023

November 6, 2023

ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA

August 29, 2023

ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents

August 22, 2023

ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA

August 13, 2023

ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update

August 13, 2023

ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023

July 31, 2023

ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update

May 14, 2023

ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023

May 3, 2023

ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Securities

May 1, 2023

ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering

April 27, 2023

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

March 13, 2023

ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023

March 6, 2023

Calls in 2023